BeOne Medicines Puts its Competitors under Pressure with its Blockbuster Drug Brukinsa - Stock Breaks out to a new Annual High!

BeOne Medicines, formerly known as BeiGene, is a biotechnology company based in Switzerland that focuses on the development of medications with an emphasis on cancer treatment. The company is in direct competition with firms like Johnson & Johnson with its blockbuster drug Brukinsa. Brukinsa is now the leading drug worldwide in the field of BTK inhibitors. The company reported strong Q3 results in early November, with revenue growth of 41% to $1.4 billion. Brukinsa alone saw a year-over-year increase of 51% to $1 billion, while the second drug...